Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

CME

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

CME

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

Tricuspid Regurgitation: Burden of Disease, Recent Evidence for Transcatheter Therapies, and How to Best Measure Success for TR Patients

CME

Tricuspid Regurgitation: Burden of Disease, Recent Evidence for Transcatheter Therapies, and How to Best Measure Success for TR Patients

Managing the Growing Epidemic of HF: The Potential Role of Shunts

CME

Managing the Growing Epidemic of HF: The Potential Role of Shunts

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty & Chordal Repair

CME

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair TCT 2022

Tricuspid Valve Therapies: Why a Transcatheter toolbox is required?

CME

Tricuspid Valve Therapies: Why a Transcatheter Toolbox is Required?

Latest Data & Therapy for Mitral & Tricuspid Valve Disease

CME

Latest Data & Therapy for Mitral & Tricuspid Valve Disease

Low-Risk Patients: The Changing Face of TAVR

CME

Low-Risk Patients: The Changing Face of TAVR

TMVR: Preparing For The Next Revolution 2019

CME

TMVR: Preparing For The Next Revolution 2019

Transcatheter Mitral Valve Repair: Preparing for the Next Revolution

CME

Transcatheter Mitral Valve Replacement: Preparing for the Next Revolution

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

TMVR: Preparing For The Next Revolution

CME

TMVR: Preparing For The Next Revolution 2018

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.